Warburg-backed Chinese Oncology Healthcare Firm Hygeia Raises $286m In HK IPO

Business - Published date: Tuesday June 30, 2020.

Hygeia Healthcare, a Chinese oncology healthcare group backed by US private equity major Warburg Pincus, raised HK$2.22... Read more

Chinese Oncology Drug Developer Tot Biopharm Raises $75.2m In HK IPO

Business - Published date: Friday November 08, 2019.

Tot Biopharm, a Chinese clinical-stage biopharma firm specialized in innovative oncology drugs and therapies, has raise... Read more